Matthias Aizenberg

Breast cancer remains one of the most significant health challenges worldwide, where the critical difference between a positive prognosis and a devastating outcome often hinges on the speed and precision of the initial diagnosis. For decades, the medical community has relied on established

The journey to bring a new medicine to market is a monumental undertaking, frequently spanning over a decade and consuming more than two billion dollars in investment, a reality that has long created a significant bottleneck in addressing pressing global health challenges. In this high-stakes

A groundbreaking analysis presented at the European Association of Cardiovascular Imaging 2025 congress has shed new light on a critical and burgeoning field of medicine, revealing that treating valvular heart disease in cancer patients can dramatically improve their survival rates. As remarkable

The U.S. Centers for Disease Control and Prevention has unexpectedly postponed the release of its annual abortion surveillance report, a critical federal document that has provided a national barometer of abortion trends for over half a century. This highly anticipated report, which was slated to

The biopharmaceutical sector is at a critical inflection point where groundbreaking scientific potential is met with unprecedented economic and regulatory pressures, reshaping the very definition of medical innovation. A convergence of advanced technologies, massive capital investments, and

For millions of people living with drug-resistant epilepsy, the hope for a cure often comes with a terrifying prospect: undergoing invasive brain surgery just to find the precise origin of their debilitating seizures. This high-stakes diagnostic journey requires surgeons to place electrodes

At the University of Southern California, a quiet revolution is underway, driven by visionary leadership and a historic philanthropic investment that is positioning the institution to fundamentally reshape how urologic cancers are diagnosed, treated, and potentially cured. Under the guidance of Dr.

In the relentless fight against aggressive brain cancers, where progress is often measured in small, hard-won increments, a major clinical trial has delivered a monumental leap forward for a specific group of patients facing a daunting diagnosis. The recently concluded STELLAR Phase 3 clinical

What if a hidden enemy within the body, silently damaging vital organs, could finally be dismantled with precision? For thousands battling rare diseases like AL amyloidosis, where toxic protein deposits wreak havoc on the heart and kidneys, this prospect is no longer a distant dream. A

Picture a high-stakes medical decision resting on the shoulders of a systematic review, the gold standard of evidence-based research, where every detail could impact patient lives. In this critical arena, artificial intelligence (AI), particularly large language models (LLMs), has emerged as a